Notes to the Financial Statements
Notes to the Financial Statements
continued
3 Revenue
Revenue
continued
2016
€’000 2015
€’000
1,296,320 1,118,638
• The financial performance of Allcare Management Services Limited in managing the Allcare franchise.
• Lindchem DAC, the acquired retail pharmacy holding company consolidating the financial performance of underlying Uniphar
owned Allcare branded pharmacy investments.
Segmental information
Segmental information is presented in respect of the Group’s geographical regions and operating segments.
The operating segments are based on the Group’s management and internal reporting structures.
2016
€’000
2015
€’000
Reconciliation of operating profit to earnings before interest, tax, depreciation and
amortisation (EBITDA):
Operating profit pre-exceptional
18,752 15,730
Depreciation (note 13) 2,919 2,444
Amortisation of computer software (note 12) 3,022 2,813
24,693 20,987
EBITDA
3 Revenue - continued
€’000 2016
Retail
Pharmacy
€’000 €’000
1,224,518 28,945 42,857 1,296,320
EBITDA 16,130 1,210 7,353 24,693
Finance cost (2,045) (136) (641) (2,822)
(693) (17) (610) (1,320)
Revenue
Income tax expense
2015
Supply
chain
€’000
Geographical analysis:
The Group operates in two principal geographical regions being the Republic of Ireland and the United Kingdom.
The following is a geographical analysis presented in accordance with IFRS 8 “Operating Segments” which requires disclosure of
information about country of domicile (Ireland) and countries with material revenue.
Ireland
UK
2016
€’000 2015
€’000
1,262,116 1,100,371
34,204 18,267
1,296,320 1,118,638
Operating segments
IFRS 8 “Operating Segments” requires the reporting information for operating segments to reflect the Group’s management structure
and the way the financial information is regularly reviewed by the Group.
The Group’s operations are divided into the following operating segments:
Supply Chain Services - The Supply Chain Services segment combines all of the Group’s healthcare logistics based companies.
CSO (Contract Sales Outsourcing) - The CSO segment encompasses the UK-based Star Medical Limited, a market leader in
the provision of recruitment and contract sales personnel for the pharmaceutical sector along with the Irish based CSO business,
Unisource Pharma Services Ireland Limited (trading as Star).
Retail Pharmacy
The retail pharmacy segment represents the activities of the following:
• IPOS pharmacies that are consolidated in the Group’s financial statements. Uniphar plc retains a controlling interest in these
pharmacies until such time as the relevant shares are redeemed under the provisions of the shareholder agreements with
purchasing pharmacists.
52 | Annual Report 2016
2016
Supply
chain
€’000
Revenue
2016
CSO
2015
CSO
€’000
2015
Retail
Pharmacy
€’000
2016
Total
2015
Total
€’000
1,083,012 18,251 17,375 1,118,638
EBITDA 17,397 215 3,375 20,987
Finance cost (2,537) (35) (366) (2,938)
Income tax credit/(expense) 1,054 (62) (324) 668
2016
€’000 2015
€’000
4 Other operating income
Other income and commission
64 18
1,635 638
1,699 656
2016
€’000 2015
€’000
Exceptional charge from investment in IPOS network (5,737) (3,268)
Other exceptional charges (net) (4,516) (4,195)
8 -
Dividends receivable from investments
5 Exceptional charge
Profit on disposal of property, plant and equipment
Profit on disposal of subsidiary undertakings (note 8)
Exceptional charge
446 103
(9,799) (7,360)
Annual Report 2016 | 53